Third report of Committee B (Draft)

SEVENTIETH WORLD HEALTH ASSEMBLY (Draft) A70/76 30 May 2017 Third report of Committee B (Draft) Committee B held its fifth and sixth meetings on 29 May 2017 under the chairmanship of Dr Molwyn Joseph (Antigua and Barbuda) and Mr Mario Miklosi (Slovakia). It was agreed to recommend to the Seventieth World Health Assembly that its current agenda item 23.2 “Governance reform: follow-up to decision WHA69(8) (2016)” be included on the agenda of the Executive Board at its 142nd session in January 2018 in order to permit, inter alia, further consideration of the two options contained in document A70/51 under the heading “Explanatory memorandum for items proposed under Rule 5 of the Rules of Procedure of the World Health Assembly”. It was also decided to recommend to the Seventieth World Health Assembly the adoption of the attached two decisions relating to the following agenda items: 15. Noncommunicable diseases 15.2 Draft global action plan on the public health response to dementia One decision 15.3 Public health dimension of the world drug problem One decision (Draft) A70/76 2 Agenda item 15.2 Draft global action plan on the public health response to dementia The Seventieth World Health Assembly, having considered the draft global action plan on the public health response to dementia 2017–2025,1 decided: (1) to endorse the global action plan on the public health response to dementia 2017–2025; (2) to urge Member States 2 to develop, as soon as practicable, ambitious national responses to the overall implementation of the global action plan on the public health response to dementia 2017–2025; (3) to request the Director-General to submit a report on progress made in implementing this decision to the Seventy-third, Seventy-sixth and Seventy-ninth World Health Assemblies. 1 Document A70/28. 2 And, where applicable, regional economic integration organizations. (Draft) A70/76 3 Agenda item 15.3 Public health dimension of the world drug problem The Seventieth World Health Assembly, having considered the report of the Secretariat on the public health dimension of the world drug problem, 1 decided: (1) to welcome the progress to strengthen and expand existing cooperation on the public health related aspects of the world drug problem, including the signing of the Memorandum of Understanding between WHO and UNODC in February 2017; (2) to recognize the need for intensified efforts to support Member States, upon request, in addressing and countering the world drug problem in accordance with a comprehensive, integrated and balanced approach; (3) to request the Director-General to continue efforts to improve coordination and collaboration of the WHO with the UNODC and the International Narcotics Control Board, within their existing mandates, in addressing and countering the world drug problem; (4) to further request the Director-General to report on the implementation of this decision to the Seventy first, Seventy-third and Seventy-fifth World Health Assemblies, and to continue to keep the Commission on Narcotics Drugs, considering its treaty based mandates, appropriately informed of relevant programmes and progress. = = = 1 Document A70/29.